#
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||Notes|Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||Funds|Funds|Funds|Funds|
||||2021|2021|2021|2020|
|Income and Endowments|from:||||F|E|
|Donations
and legacies|||3,848||3,848|6,664|
|Total income|||||3,848|6,664|
|Expenditure
on:|||||||
|Charitable
activities|||1,532||1,532|2, 19'I|
|Total expenditure|||1,532||1,532|2,191|
|Net income, net movement
funds|in||2,316||2,316|4,473|
|Total funds brought forward||8,9|12,939||12,939|8,466|
|Total funds carried forward||7-9|15,255||15,255|12,939|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||2021|2020|
|---|---|---|---|---|
|Direct Charitabfe|Expenditure:||||
|World Asthma
day|||||
|Materials|||70|201|
|Pharmacy
costs||||689|
|Venue hire||||50|
||||70|940|
|Support and governance||costs:|||
|Travel expenses|||1,146|502|
|Refreshments||||114|
|Computer costs||||$00|
|Training||||180|
|Sundry||||30|
|Accountancy
fees|||280|325|
||||1,462|1,251|
|Total expenditure
activities|on Charitable||1,532|2,191|
##
##
##
##
##
##
|Analysis
2021|of|net assets|between
Funds|||||
|---|---|---|---|---|---|---|---|
|||||Tangible|Met|Total||
|||||fixed|current|||
|||||assets|assets|||
|Unrestricted||Funds||||||
|General|Fund|||||||
||||||15,255|15,255||
|Restricted||Funds||||||
|Totals|||||15,255|15,255||
|2020||||||||
|||||Tangible|Net|Total||
|||||fixed|current|||
|Unrestricted||Funds||assets|assetsf|||
|General|Fund||||12,939|12,939||
|Restricted Funds||||||||
|Totals|||||12,939|12,939||
|Unrestricted||funds||||||
|2021||||||||
|||||Movements
in||the Year||
||||Resources|income|Expenditure||Resources|
||||at beginning||||at End|
||||ofYear||||ofYear|
|General|Fund||12,939|3,848||1,532|15,255|
|2020||||||||
|||||Movements
in||the Year||
||||Resources|Income|Expenditure||Resources|
||||at beginning||||at End|
||||ofYear|||f|ofYear|
|General|Fund||8,466|6,664||(2,191)|12,939|
##
##
##
##